The Expression Profile of PD-1 and its Ligand PD-L1 in Human Monocytes and Breast Cancer
Breast cancer is the most common type of cancer in women and there are different types of breast cancers. Although the survival among breast cancer patients has improved the last decade, there is still a large group of patients with a bad prognosis. In recent years, a new set of immunotherapies called immune checkpoint inhibitors targeting the regulatory receptors in T-cell activation and activity